Literature DB >> 26520413

The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes.

Cassie M Mitchell1, Brenda M Davy1, Tanya M Halliday1, Mathew W Hulver2, Andrew P Neilson3, Monica A Ponder4, Kevin P Davy5.   

Abstract

Prediabetes is associated with low-grade chronic inflammation that increases the risk for developing type 2 diabetes (T2D) and cardiovascular disease (CVD). An elevated lipopolysaccharide concentration, associated with dysbiosis of the intestinal microbiota, has been implicated in the development of both T2D and CVD. Selective modulation of the intestinal microbiota with prebiotics reduces intestinal permeability and endotoxin concentrations, inflammation, and metabolic dysfunction in rodents. The effect of prebiotic supplementation on cardio-metabolic function in humans at risk for T2D is not known. The primary aim of this trial is to determine the influence of prebiotic supplementation with inulin on insulin sensitivity and skeletal muscle metabolic flexibility in adults at risk for T2D. We hypothesize that prebiotic supplementation with inulin will improve insulin sensitivity and skeletal muscle metabolic flexibility. We will randomize 48 adults (40-75 yrs) with prediabetes or a score ≥ 5 on the American Diabetes Association (ADA) risk screener to 6 weeks of prebiotic supplementation with inulin (10 g/day) or placebo. Subjects will be provided with all food for the duration of the study, to avoid potential confounding through differences in dietary intake between individuals. Intestinal permeability, serum endotoxin concentrations, insulin sensitivity, skeletal muscle metabolic flexibility, endothelial function, arterial stiffness, and fecal bacterial composition will be measured at baseline and following treatment. The identification of prebiotic supplementation with inulin as an efficacious strategy for reducing cardio-metabolic risk in individuals at risk of T2D could impact clinical practice by informing dietary recommendations and increasing acceptance of prebiotics by the scientific and medical community.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Diabetes; Diet; Microbiome; Prebiotics

Mesh:

Substances:

Year:  2015        PMID: 26520413      PMCID: PMC4743874          DOI: 10.1016/j.cct.2015.10.012

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  76 in total

Review 1.  Assessment of flow-mediated dilation in humans: a methodological and physiological guideline.

Authors:  Dick H J Thijssen; Mark A Black; Kyra E Pyke; Jaume Padilla; Greg Atkinson; Ryan A Harris; Beth Parker; Michael E Widlansky; Michael E Tschakovsky; Daniel J Green
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

2.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

3.  Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans.

Authors:  Matthew W Hulver; Jason R Berggren; Michael J Carper; Makoto Miyazaki; James M Ntambi; Eric P Hoffman; John P Thyfault; Robert Stevens; G Lynis Dohm; Joseph A Houmard; Deborah M Muoio
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

Review 4.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.

Authors:  G R Gibson; M B Roberfroid
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

5.  The role of bifidobacteria in gut barrier function after thermal injury in rats.

Authors:  Zhongtang Wang; Guangxia Xiao; Yongming Yao; Shuzhong Guo; Kaihua Lu; Zhiyong Sheng
Journal:  J Trauma       Date:  2006-09

6.  Acute systemic inflammation impairs endothelium-dependent dilatation in humans.

Authors:  A D Hingorani; J Cross; R K Kharbanda; M J Mullen; K Bhagat; M Taylor; A E Donald; M Palacios; G E Griffin; J E Deanfield; R J MacAllister; P Vallance
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

7.  Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

8.  Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease.

Authors:  Milan Dastych; Milan Dastych; Hana Novotná; J Cíhalová
Journal:  Dig Dis Sci       Date:  2008-03-05       Impact factor: 3.199

9.  Endotoxemia is associated with an increased risk of incident diabetes.

Authors:  Pirkko J Pussinen; Aki S Havulinna; Markku Lehto; Jouko Sundvall; Veikko Salomaa
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

Review 10.  Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.

Authors:  Nathalie M Delzenne; Audrey M Neyrinck; Patrice D Cani
Journal:  Microb Cell Fact       Date:  2011-08-30       Impact factor: 5.328

View more
  13 in total

Review 1.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.

Authors:  Junli Ma; Qihang Zhou; Houkai Li
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

Review 2.  Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.

Authors:  Amanda Cuevas-Sierra; Omar Ramos-Lopez; Jose I Riezu-Boj; Fermin I Milagro; J Alfredo Martinez
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

3.  Alleviation of Metabolic Endotoxemia by Milk Fat Globule Membrane: Rationale, Design, and Methods of a Double-Blind, Randomized, Controlled, Crossover Dietary Intervention in Adults with Metabolic Syndrome.

Authors:  William R Quarles; Avi Pokala; Emily L Shaw; Joana Ortega-Anaya; Lisa Hillmann; Rafael Jimenez-Flores; Richard S Bruno
Journal:  Curr Dev Nutr       Date:  2020-07-25

4.  Successful collection of stool samples for microbiome analyses from a large community-based population of elderly men.

Authors:  Melanie Abrahamson; Elizabeth Hooker; Nadim J Ajami; Joseph F Petrosino; Eric S Orwoll
Journal:  Contemp Clin Trials Commun       Date:  2017-07-06

Review 5.  The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals.

Authors:  Petra C Vinke; Sahar El Aidy; Gertjan van Dijk
Journal:  Front Nutr       Date:  2017-07-24

Review 6.  The role of gut microbiota in the effects of maternal obesity during pregnancy on offspring metabolism.

Authors:  Liyuan Zhou; Xinhua Xiao
Journal:  Biosci Rep       Date:  2018-04-13       Impact factor: 3.840

7.  Inulin Supplementation Does Not Reduce Plasma Trimethylamine N-Oxide Concentrations in Individuals at Risk for Type 2 Diabetes.

Authors:  Mary Elizabeth Baugh; Cortney N Steele; Christopher J Angiletta; Cassie M Mitchell; Andrew P Neilson; Brenda M Davy; Matthew W Hulver; Kevin P Davy
Journal:  Nutrients       Date:  2018-06-20       Impact factor: 5.717

Review 8.  The Effect of Dietary Fibre on Gut Microbiota, Lipid Profile, and Inflammatory Markers in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Authors:  Omorogieva Ojo; Osarhumwese Osaretin Ojo; Nazanin Zand; Xiaohua Wang
Journal:  Nutrients       Date:  2021-05-26       Impact factor: 5.717

Review 9.  Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions.

Authors:  Miguel Toribio-Mateas
Journal:  Microorganisms       Date:  2018-04-25

Review 10.  The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome.

Authors:  Maret G Traber; Garry R Buettner; Richard S Bruno
Journal:  Redox Biol       Date:  2018-12-26       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.